A new stereospecific synthesis of 1,2,4-Trideoxy-1,4-imino-D-erythro-pentitol

Article abstract of DOI:10.1080/07328300008544100

1,2,4-Trideoxy-1,4-imino-D-erythro-pentitol [(2R,3S)-3-hydroxy-2-hydroxymethylpyrrolidine] (4) was synthesised from 2,5-di-O-tosyl-D-ribono-1,4-lactone in 42 % overall yield. The key steps were deoxygenation at C-2 and a stereospecific inversion of the co

Full text of DOI:10.1080/07328300008544100

This article was downloaded by: [University of Arizona]
On: 28 November 2012, At: 01:39
Publisher: Taylor & Francis
Informa Ltd Registered in England and Wales Registered Number: 1072954
Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK
Journal of Carbohydrate Chemistry
Publication details, including instructions for authors and
subscription information:
http://www.tandfonline.com/loi/lcar20
A New Stereospecific Synthesis of
1,2,4-Trideoxy-1,4-Imino-D-Erythro-
Pentitol
Birgitte Mølholm Malle, Inge Lundt & Richard H. Furneaux
a Department of Organic Chemistry, Technical University of
Denmark, Building 201, DK-2800 Lyngby, Denmark
b Carbohydrate Chemistry Team, Industrial Research Limited,
P O Box 31310, Lower Hutt, New Zealand
Version of record first published: 07 Mar 2008.
To cite this article: Birgitte Mølholm Malle, Inge Lundt & Richard H. Furneaux (2000): A
New Stereospecific Synthesis of 1,2,4-Trideoxy-1,4-Imino-D-Erythro-Pentitol, Journal of
Carbohydrate Chemistry, 19:4-5, 573-583
To link to this article: http://dx.doi.org/10.1080/07328300008544100
PLEASE SCROLL DOWN FOR ARTICLE
Full terms and conditions of use: http://www.tandfonline.com/page/terms-and-
conditions
This article may be used for research, teaching, and private study purposes. Any
substantial or systematic reproduction, redistribution, reselling, loan, sub-licensing,
systematic supply, or distribution in any form to anyone is expressly forbidden.
The publisher does not give any warranty express or implied or make any
representation that the contents will be complete or accurate or up to date. The
accuracy of any instructions, formulae, and drug doses should be independently
verified with primary sources. The publisher shall not be liable for any loss, actions,
claims, proceedings, demand, or costs or damages whatsoever or howsoever caused
arising directly or indirectly in connection with or arising out of the use of this
material.